Pioglitazone is as effective as dexamethasone in a cockroach allergen-induced murine model of asthma

Respiratory Research

Volumn 8, Issue , 2007, Pages

  Narala, Venkata R ^a   Ranga, Rajesh ^a   Smith, Monica R ^a   Berlin, Aaron A ^a   Standiford, Theodore J ^a   Lukacs, Nicholas W ^a   Reddy, Raju C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALLERGEN; ALLERGEN CRA, COCKROACH; DEXAMETHASONE; PIOGLITAZONE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; ASTHMA; BAGG ALBINO MOUSE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DISEASE MODEL; FEMALE; MOUSE;

ALLERGENS; ANIMALS; ASTHMA; DEXAMETHASONE; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, INBRED BALB C; THIAZOLIDINEDIONES;

EID: 41649116684     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-8-90     Document Type: Article

References (67)

1. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999, 17:255-281. 10.1146/annurev.immunol.17.1.255, 10358759.
2. Ying S, Zhang G, Gu S, Zhao J. How much do we know about atopic asthma: where are we now?. Cell Mol Immunol 2006, 3(5):321-332.
3. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 1995, 332(13):868-875. 10.1056/NEJM199503303321307, 7870143.
4. Mjaanes CM, Whelan GJ, Szefler SJ. Corticosteroid therapy in asthma: predictors of responsiveness. Clin Chest Med 2006, 27(1):119-132. 10.1016/j.ccm.2005.10.005, 16543057.
5. Glass CK, Ogawa S. Combinatorial roles of nuclear receptors in inflammation and immunity. Nat Rev Immunol 2006, 6(1):44-55. 10.1038/nri1748, 16493426.
6. Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 2000, 49(10):497-505. 10.1007/s000110050622, 11089900.
7. Becker J, Delayre-Orthez C, Frossard N, Pons F. Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?. Fundam Clin Pharmacol 2006, 20(5):429-447. 10.1111/j.1472-8206.2006.00425.x, 16968414.
8. Huang TH-W, Razmovski-Naumovski V, Kota BP, Lin DS-H, Roufogalis BD. The pathophysiological function of peroxisome proliferator-activated receptor-γ in lung-related diseases. Respir Res 2005, 6:102. 1242255, 16153299, 10.1186/1465-9921-6-102.
9. Jiang C, Ting AT, Seed B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 1998, 391(6662):82-86. 10.1038/34184, 9422509.
10. Sugiyama H, Nonaka T, Kishimoto T, Komoriya K, Tsuji K, Nakahata T. Peroxisome proliferator-activated receptors are expressed in human cultured mast cells: a possible role of these receptors in negative regulation of mast cell activation. Eur J Immunol 2000, 30(12):3363-3370. 10.1002/1521-4141(2000012)30:12<3363::AID-IMMU3363>3.0.CO;2-B, 11093153.
11. Reddy RC, Keshamouni VG, Jaigirdar SH, Zeng X, Leff T, Thannickal VJ, Standiford TJ. Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-γ ligands. Am J Physiol Lung Cell Mol Physiol 2004, 286(3):L613-619. 10.1152/ajplung.00206.2003, 14617516.
12. Wang ACC, Dai X, Luu B, Conrad DJ. Peroxisome proliferator-activated receptor-γ regulates airway epithelial cell activation. Am J Respir Cell Mol Biol 2001, 24(6):688-693.
13. Patel HJ, Belvisi MG, Bishop-Bailey D, Yacoub MH, Mitchell JA. Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy. J Immunol 2003, 170(5):2663-2669.
14. Ueki S, Usami A, Oyamada H, Saito N, Chiba T, Mahemuti G, Ito W, Kato H, Kayaba H, Chihara J. Procaterol upregulates peroxisome proliferator-activated receptor-γ expression in human eosinophils. Int Arch Allergy Immunol 2006, 140(Suppl 1):35-41. 10.1159/000092709, 16772725.
15. Woerly G, Honda K, Loyens M, Papin JP, Auwerx J, Staels B, Capron M, Dombrowicz D. Peroxisome proliferator-activated receptors α and γ down-regulate allergic inflammation and eosinophil activation. J Exp Med 2003, 198(3):411-421. 10.1084/jem.20021384, 12900517.
16. Denning GM, Stoll LL. Peroxisome proliferator-activated receptors: potential therapeutic targets in lung disease?. Pediatr Pulmonol 2006, 41(1):23-34. 10.1002/ppul.20338, 16267824.
17. Spears M, McSharry C, Thomson NC. Peroxisome proliferator-activated receptor-γ agonists as potential anti-inflammatory agents in asthma and chronic obstructive pulmonary disease. Clin Exp Allergy 2006, 36(12):1494-1504. 10.1111/j.1365-2222.2006.02604.x, 17177672.
18. Belvisi MG, Hele DJ, Birrell MA. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation. Eur J Pharmacol 2006, 533(1-3):101-109. 10.1016/j.ejphar.2005.12.048, 16458290.
19. Arruda LK, Vailes LD, Platts-Mills TAE, Hayden ML, Chapman MD. Induction of IgE antibody responses by glutathione S-transferase from the German cockroach (Blattella germanica). J Biol Chem 1997, 272(33):20907-20912. 10.1074/jbc.272.33.20907, 9252418.
20. Kang B, Vellody D, Homburger H, Yunginger JW. Cockroach cause of allergic asthma. Its specificity and immunologic profile. J Allergy Clin Immunol 1979, 63(2):80-86. 10.1016/0091-6749(79)90196-9, 83332.
21. Rosenstreich DL, Eggleston P, Kattan M, Baker D, Slavin RG, Gergen P, Mitchell H, McNiff-Mortimer K, Lynn H, Ownby D, et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med 1997, 336(19):1356-1363. 10.1056/NEJM199705083361904, 9134876.
22. Campbell EM, Kunkel SL, Strieter RM, Lukacs NW. Temporal role of chemokines in a murine model of cockroach allergen-induced airway hyperreactivity and eosinophilia. J Immunol 1998, 161(12):7047-7053.
23. Sarpong SB, Zhang LY, Kleeberger SR. A novel mouse model of experimental asthma. Int Arch Allergy Immunol 2003, 132(4):346-354. 10.1159/000074902, 14707466.
24. Kung TT, Jones H, Adams GK, Umland SP, Kreutner W, Egan RW, Chapman RW, Watnick AS. Characterization of a murine model of allergic pulmonary inflammation. Int Arch Allergy Immunol 1994, 105(1):83-90.
25. Akahori T, Sho M, Hamada K, Suzaki Y, Kuzumoto Y, Nomi T, Nakamura S, Enomoto K, Kanehiro H, Nakajima Y. Importance of peroxisome proliferator-activated receptor-gamma in hepatic ischemia/reperfusion injury in mice. J Hepatol 2007, 47(6):784-792. 10.1016/j.jhep.2007.07.030, 17936399.
26. Kubota N, Terauchi Y, Kubota T, Kumagai H, Itoh S, Satoh H, Yano W, Ogata H, Tokuyama K, Takamoto I, et al. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and - independent pathways. J Biol Chem 2006, 281(13):8748-8755. 10.1074/jbc.M505649200, 16431926.
27. Srinivasan K, Patole PS, Kaul CL, Ramarao P. Reversal of glucose intolerance by by pioglitazone in high fat diet-fed rats. Methods Find Exp Clin Pharmacol 2004, 26(5):327-333. 10.1358/mf.2004.26.5.831322, 15319810.
28. Blyth DI, Wharton TF, Pedrick MS, Savage TJ, Sanjar S. Airway subepithelial fibrosis in a murine model of atopic asthma: suppression by dexamethasone or anti-interleukin-5 antibody. Am J Respir Cell Mol Biol 2000, 23(2):241-246.
29. Christie PE, Jonas M, Tsai C-H, Chi E-Y, Henderson WR. Increase in laminin expression in allergic airway remodelling and decrease by dexamethasone. Eur Respir J 2004, 24(1):107-115. 10.1183/09031936.04.00013303, 15293612.
30. Kim J, McKinley L, Siddiqui J, Bolgos GL, Remick DG. Prevention and reversal of pulmonary inflammation and airway hyperresponsiveness by dexamethasone treatment in a murine model of asthma induced by house dust. Am J Physiol Lung Cell Mol Physiol 2004, 287(3):L503-509. 10.1152/ajplung.00433.2003, 15132954.
31. Roh GS, Shin Y, Seo S-W, Yoon BR, Yeo S, Park SJ, Cho JW, Kwack K. Proteome analysis of differential protein expression in allergen-induced asthmatic mice lung after dexamethasone treatment. Proteomics 2004, 4(11):3318-3327. 10.1002/pmic.200400930, 15378748.
32. Lukacs NW, Strieter RM, Warmington K, Lincoln P, Chensue SW, Kunkel SL. Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation. J Immunol 1997, 158(9):4398-4404.
33. Li Y, Lazar MA. Differential gene regulation by PPARγ agonist and constitutively active PPARγ2. Mol Endocrinol 2002, 16(5):1040-1048. 10.1210/me.16.5.1040, 11981038.
34. Aoki K, Barker C, Danthinne X, Imperiale MJ, Nabel GJ. Efficient generation of recombinant adenoviral vectors by Cre-lox recombination in vitro. Mol Med 1999, 5(4):224-231.
35. Keshamouni VG, Reddy RC, Arenberg DA, Joel B, Thannickal VJ, Kalemkerian GP, Standiford TJ. Peroxisome proliferator-activated receptor-γ activation inhibits tumor progression in non-small-cell lung cancer. Oncogene 2004, 23(1):100-108. 10.1038/sj.onc.1206885, 14712215.
36. Hammad H, de Heer HJ, Soullié T, Angeli V, Trottein F, Hoogsteden HC, Lambrecht BN. Activation of peroxisome proliferator-activated receptor-γ in dendritic cells inhibits the development of eosinophilic airway inflammation in a mouse model of asthma. Am J Pathol 2004, 164(1):263-271. 1602239, 14695339.
37. Lee KS, Kim SR, Park SJ, Park HS, Min KH, Jin SM, Lee MK, Kim UH, Lee YC. Peroxisome proliferator activated receptor-γ modulates reactive oxygen species generation and activation of nuclear factor-κB and hypoxia-inducible factor 1α in allergic airway disease of mice. J Allergy Clin Immunol 2006, 118(1):120-127. 10.1016/j.jaci.2006.03.021, 16815147.
38. Lee KS, Park SJ, Hwang PH, Yi HK, Song CH, Chai OH, Kim JS, Lee MK, Lee YC. PPAR-gamma modulates allergic inflammation through up-regulation of PTEN. FASEB J 2005, 19(8):1033-1035.
39. Lee KS, Park SJ, Kim SR, Min KH, Jin SM, Lee HK, Lee YC. Modulation of airway remodeling and airway inflammation by peroxisome proliferator-activated receptor γ in a murine model of toluene diisocyanate-induced asthma. J Immunol 2006, 177(8):5248-5257.
40. Honda K, Marquillies P, Capron M, Dombrowicz D. Peroxisome proliferator-activated receptor γ is expressed in airways and inhibits features of airway remodeling in a mouse asthma model. J Allergy Clin Immunol 2004, 113(5):882-888. 10.1016/j.jaci.2004.02.036, 15131570.
41. Kim SR, Lee KS, Park HS, Park SJ, Min KH, Jin SM, Lee YC. Involvement of IL-10 in peroxisome proliferator-activated receptor γ-mediated anti-inflammatory response in asthma. Mol Pharmacol 2005, 68(6):1568-1575.
42. Mueller C, Weaver V, Vanden Heuvel JP, August A, Cantorna MT. Peroxisome proliferator-activated receptor γ ligands attenuate immunological symptoms of experimental allergic asthma. Arch Biochem Biophys 2003, 418(2):186-196. 10.1016/j.abb.2003.08.006, 14522590.
43. Trifilieff A, Bench A, Hanley M, Bayley D, Campbell E, Whittaker P. PPAR-α and -γ but not -δ agonists inhibit airway inflammation in a murine model of asthma:in vitro evidence for an NF-κB-independent effect. Br J Pharmacol 2003, 139(1):163-171. 10.1038/sj.bjp.0705232, 12746235.
44. Birrell MA, Battram CH, Woodman P, McCluskie K, Belvisi MG. Dissociation by steroids of eosinophilic inflammation from airway hyperresponsiveness in murine airways. Respir Res 2003, 4:3. 152648, 12657158, 10.1186/rr197.
45. Christie PE, Jonas M, Tsai C-H, Chi EY, Henderson WR. Increase in laminin expression in allergic airway remodelling and decrease by dexamethasone. Eur Respir J 2004, 24(1):107-115. 10.1183/09031936.04.00013303, 15293612.
46. De Bie JJ, Hessel EM, Van Ark I, Van Esch B, Hofman G, Nijkamp FP, Van Oosterhout AJ. Effect of dexamethasone and endogenous corticosterone on airway hyperresponsiveness and eosinophilia in the mouse. Br J Pharmacol 1996, 119(7):1484-1490.
47. Eum S-Y, Maghni K, Hamid Q, Eidelman DH, Campbell H, Isogai S, Martin JG. Inhibition of allergic airways inflammation and airway hyperresponsiveness in mice by dexamethasone: role of eosinophils, IL-5, eotaxin, and IL-13. J Allergy Clin Immunol 2003, 111(5):1049-1061. 10.1067/mai.2003.1416, 12743570.
48. Jungsuwadee P, Dekan G, Stingl G, Epstein MM. Inhaled dexamethasone differentially attenuates disease relapse and established allergic asthma in mice. Clin Immunol 2004, 110(1):13-21. 10.1016/j.clim.2003.09.003, 14962792.
49. Kumar RK, Herbert C, Thomas PS, Wollin L, Beume R, Yang M, Webb DC, Foster PS. Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthma. J Pharmacol Exp Ther 2003, 307(1):349-355. 10.1124/jpet.103.053819, 12954795.
50. Kurokawa M, Kokubu F, Matsukura S, Kawaguchi M, Ieki K, Suzuki S, Odaka M, Watanabe S, Takeuchi H, Akabane T, et al. Effects of corticosteroid on the expression of thymus and activation-regulated chemokine in a murine model of allergic asthma. Int Arch Allergy Immunol 2005, 137(Suppl 1):60-68. 10.1159/000085434, 15947487.
51. Miller M, Cho JY, McElwain K, McElwain S, Shim JY, Manni M, Baek JS, Broide DH. Corticosteroids prevent myofibroblast accumulation and airway remodeling in mice. Am J Physiol Lung Cell Mol Physiol 2006, 290(1):L162-169. 10.1152/ajplung.00252.2005, 16344333.
52. Sun J, Deng Y, Wu X, Tang H, Deng J, Chen J, Yang S, Xie Q. Inhibition of phosphodiesterase activity, airway inflammation and hyperresponsiveness by PDE4 inhibitor and glucocorticoid in a murine model of allergic asthma. Life Sci 2006, 79(22):2077-2085. 10.1016/j.lfs.2006.07.001, 16875702.
53. Trifilieff A, El-Hashim A, Bertrand C. Time course of inflammatory and remodeling events in a murine model of asthma: effect of steroid treatment. Am J Physiol Lung Cell Mol Physiol 2000, 279(6):L1120-1128.
54. Zhang Y, Adner M, Cardell L-O. Glucocorticoids suppress transcriptional up-regulation of bradykinin receptors in a murine in vitro model of chronic airway inflammation. Clin Exp Allergy 2005, 35(4):531-538. 10.1111/j.1365-2222.2005.02207.x, 15836764.
55. Zhao J, Yeong LH, Wong WS. Dexamethasone alters bronchoalveolar lavage fluid proteome in a mouse asthma model. Int Arch Allergy Immunol 2007, 142(3):219-229. 10.1159/000097024, 17108703.
56. Eum S-Y, Creminon C, Haile S, Lefort J, Vargaftig BB. Inhibition of airways inflammation by dexamethasone is followed by reduced bronchial hyperreactivity in BP2 mice. Clin Exp Allergy 1996, 26(8):971-979. 10.1111/j.1365-2222.1996.tb00635.x, 8877165.
57. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 1998, 391(6662):79-82. 10.1038/34178, 9422508.
58. Standiford TJ, Keshamouni VG, Reddy RC. Peroxisome proliferator-activated receptor-γ as a regulator of lung inflammation and repair. Proc Am Thorac Soc 2005, 2(3):226-231. 10.1513/pats.200501-010AC, 16222042.
59. Nencioni A, Grunebach F, Zobywlaski A, Denzlinger C, Brugger W, Brossart P. Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor γ. J Immunol 2002, 169(3):1228-1235.
60. Padilla J, Kaur K, Cao HJ, Smith TJ, Phipps RP. Peroxisome proliferator activator receptor-γ agonists and 15-Deoxy-Δ12,14-PGJ2 induce apoptosis in normal and malignant B-lineage cells. J Immunol 2000, 165(12):6941-6948.
61. Clark RB, Bishop-Bailey D, Estrada-Hernandez T, Hla T, Puddington L, Padula SJ. The nuclear receptor PPARγ and immunoregulation: PPARγ mediates inhibition of helper T cell responses. J Immunol 2000, 164(3):1364-1371.
62. Cunard R, Eto Y, Muljadi JT, Glass CK, Kelly CJ, Ricote M. Repression of IFN-γ expression by peroxisome proliferator-activated receptor γ. J Immunol 2004, 172(12):7530-7536.
63. Yang XY, Wang LH, Chen T, Hodge DR, Resau JH, DaSilva L, Farrar WL. Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor γ (PPARγ) agonists. PPARγ co-association with transcription factor NFAT. J Biol Chem 2000, 275(7):4541-4544. 10.1074/jbc.275.7.4541, 10671476.
64. Zhang X, Rodriguez-Galan MC, Subleski JJ, Ortaldo JR, Hodge DL, Wang JM, Shimozato O, Reynolds DA, Young HA. Peroxisome proliferator-activated receptor-γ and its ligands attenuate biologic functions of human natural killer cells. Blood 2004, 104(10):3276-3284. 10.1182/blood-2004-02-0664, 15265789.
65. Berlin AA, Hogaboam CM, Lukacs NW. Inhibition of SCF attenuates peribronchial remodeling in chronic cockroach allergen-induced asthma. Lab Invest 2006, 86(6):557-565.
66. Usami A, Ueki S, Ito W, Kobayashi Y, Chiba T, Mahemuti G, Oyamada H, Kamada Y, Fujita M, Kato H, et al. Theophylline and dexamethasone induce peroxisome proliferator-activated receptor-γ expression in human eosinophils. Pharmacology 2006, 77(1):33-37. 10.1159/000092376, 16569937.
67. Nie M, Corbett L, Knox AJ, Pang L. Differential regulation of chemokine expression by peroxisome proliferator-activated receptor γ agonists: interactions with glucocorticoids and β2-agonists. J Biol Chem 2005, 280(4):2550-2561. 10.1074/jbc.M410616200, 15531761.